The vaccine against the coronavirus, jointly developed by Oxford University and pharmaceutical company AstraZeneca, began use in the United Kingdom on Monday.
According to the UK division of the British Public Health Service (NHS)
Oxford resident Brian Pinker was the world’s first to receive the vaccine.
Pinker is 82 and needs dialysis, so he’s among those at risk in two ways, and thus is among the first to be vaccinated.
The list of priorities set by the British government’s Joint Committee on Vaccination and Immunization (JCVI) last year classifies the population into age groups according to age and health status, people over 80 with chronic health problems and health and care workers are in the highest priority group. .
The Oxford/AstraZeneca vaccine, which was approved by the British Medicines Agency (MHRA) last week, is the second vaccine after the joint vaccine between Pfizer and BioNtech to be launched in the UK.
The main advantage of the Oxford / AstraZeneca vaccine is that it does not require deep freezing during transportation, and can be kept at normal refrigerator temperatures from production to use.
The Pfizer and BioNTech vaccine should be stored at minus 70 degrees during transportation, although this vaccine can be stored at 2-8 degrees in normal refrigerator temperature for five days after delivery.
The UK government has so far linked 50 million doses of the Pfizer/BioNTech vaccine and hundreds of millions of doses of the Oxford/AstraZeneca vaccine.
The mass vaccination campaign began in Britain on December 8, and the British Minister of Health Matt Hancock announced on the first day of the new year that it had reached one million vaccines.
Commenting on the start of use of the Oxford/AstraZeneca vaccine on Monday, a BBC program on BBC British Public Service Television said there would be more difficult weeks, but vaccines were already the way out of the coronavirus pandemic.
Referring to the reshaping of the dosing schedule in the UK, the minister said it was now known that the first dose also provided protection, so you could wait up to 12 weeks to administer the second dose.
Two doses of the two vaccines approved so far should be administered. However, on the recommendation of the JCVI, the UK government has shifted focus from giving the second dose as quickly as possible. The aim is to ensure that as many members of the most vulnerable groups as possible receive the first dose as soon as possible, so that they can quickly develop protection against the serious illnesses caused by coronavirus infection.
Accordingly, instead of the previous three-week time difference, administration of the first dose may be followed by administration of the second dose within 12 weeks.
Chris Whitty of England, Michael McBride of Northern Ireland, Gregor Smith of Scotland, Frank Atherton of Wales, deputy chief of staff, and Jonathan Van Tam of England, deputy chief of staff, said in a joint resolution presented by the Department of Health last week: after taking a dose.
According to senior physicians, it is clearly more beneficial from a public health point of view to be able to vaccinate twice as many people in the next two to three months, and to shift focus to the first dose as soon as possible, by concentrating on both doses as quickly as possible.